within Pharmacolibrary.Drugs.ATC.N;

model N05CB02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 0.1 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,
    adminCount     = 1,
    Vd             = 0.0007,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0006666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Barbiturates are central nervous system depressants once used for sedation, anesthesia induction, and management of seizure disorders. Combinations with other agents (such as analgesics or other sedative-hypnotics) were used historically for insomnia, psychiatric indications, or pain relief; however, due to a high risk of dependence, overdose, and drug interactions, these combinations are rarely used or approved today.</p><h4>Pharmacokinetics</h4><p>No published population pharmacokinetic study reporting compartmental model parameters for 'barbiturates in combination with other drugs' (ATC N05CB02) could be identified. Estimated parameters below are provided based on typical values for oral barbiturates (such as phenobarbital or amobarbital) in adult, healthy subjects.</p><h4>References</h4><ol><li><p>Eriksson, AS, et al., &amp; Boreus, L (1996). Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy. <i>Epilepsia</i> 37(8) 769–773. DOI:<a href=&quot;https://doi.org/10.1111/j.1528-1157.1996.tb00650.x&quot;>10.1111/j.1528-1157.1996.tb00650.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8764817/&quot;>https://pubmed.ncbi.nlm.nih.gov/8764817</a></p></li><li><p>Bint, AJ, &amp; Burtt, I (1980). Adverse antibiotic drug interactions. <i>Drugs</i> 20(1) 57–68. DOI:<a href=&quot;https://doi.org/10.2165/00003495-198020010-00004&quot;>10.2165/00003495-198020010-00004</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6995091/&quot;>https://pubmed.ncbi.nlm.nih.gov/6995091</a></p></li><li><p>Hvidberg, EF, &amp; Dam, M (1976). Clinical pharmacokinetics of anticonvulsants. <i>Clinical pharmacokinetics</i> 1(3) 161–188. DOI:<a href=&quot;https://doi.org/10.2165/00003088-197601030-00001&quot;>10.2165/00003088-197601030-00001</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/797496/&quot;>https://pubmed.ncbi.nlm.nih.gov/797496</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N05CB02;
